Even before the U.S. threatened to bar international students and besieged universities, China’s huge spending campaign on ...

Osteoarthritis (OA), long seen as a natural byproduct of aging, is rapidly emerging as a major global health concern.

So far, China has made no official public threat about weaponizing its dominant position in this segment of the ...

African students have traded academic institutions in the West for Chinese alternatives. The Trump administration’s clampdown ...

The drug, Mazdutide, is the world's first and currently only GCG/GLP-1 dual receptor agonist targeting both weight loss and ...

In 2018, China’s biggest ejiao manufacturer raised the price of its products by 6pc, a decision based on the market supply ...

Since its reinstatement in 1977, the unified exam, known as the gaokao, has transformed millions of lives through merit-based ...

A new study published in Nature Microbiology has uncovered significant genetic and antigenic diversity among H9N2 avian ...

Mazdutide, used in the treatment of obesity and metabolic diseases, could become the first domestically-developed dual-target ...

Southwest Medical University in Sichuan province has taken a significant step in its international medical education ...

The United States' move to slash research funding for science and technology and revoke visas of Chinese students is driving ...